It’s usually a sign of what is integrated marketing communication, or IMC. Think of it like a well-rehearsed band, where ...
Immunocore reports positive initial data for HIV treatment candidate IMC-M113V, showing safety and signs of viral control post-treatment. The observation of delayed viral rebound and/or viremia ...
Immunocore Holdings plc had net KIMMTRAK product revenues of $57.8 million generated in Q2 2023. Release of results from phase 1/2 study, using IMC-F106C for the treatment of various cancers, expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback